Rev Med UAS
Vol. 13: No. 1. Enero-Marzo 2023
ISSN 2007-8013

Conocimiento sobre bioseguridad para el manejo de medicamentos citostáticos en el personal de un Centro Especializado en Atención Oncológica

Knowledge about biosafety for the management of cytostatic drugs in the staff of a Specialized Center for Oncology Care

Renovato-Hernández Claudia Sofia1, Lagunillas-Esparza Bonifacia1, Ávila-Silva Rosa Isela1, Gallegos-García Verónica2, Reyes-Laris Pedro3, Medina-de la Cruz Omar2,4,5*

  1. Centro Regional de Enfermedades Oncológicas de San Luis Potosí.
  2. Facultad de Enfermería y Nutrición. Universidad Autónoma de San Luis Potosí.
  3. Hospital General de Zona No.2. Instituto Mexicano del Seguro Social.
  4. Hospital General de Zona No.50. Instituto Mexicano del Seguro Social.
  5. Departamento de Atención a la Salud de la Infancia y la Adolescencia. Servicios de Salud de San Luis Potosí.

* Correspondencia: Omar Medina de la Cruz
Facultad de Enfermería y Nutrición. Universidad Autónoma de San Luis Potosí.
Niño Artillero No. 130, Zona Universitaria. C.P. 78290. San Luis Potosí, S.L.P. México.
e-mail: omar.medina@uaslp.mx

DOI http://dx.doi.org/10.28960/revmeduas.2007-8013.v13.n1.002

Texto Completo PDF

Recibido 16 de febrero 2023, aceptado 24 de marzo de 2023

RESUMEN
Objetivo. Evaluar el nivel de conocimiento sobre la bioseguridad en el manejo de medicamentos citostáticos que tiene el personal de un Centro Especializado en Atención Oncológica. Material y métodos. Investigación exploratoria de corte transversal, realizada en un Centro en Atención Oncológica privado de la ciudad de San Luis Potosí. Se aplicó un instrumento validado a 12 participantes para evaluar el nivel de conocimiento, se realizó estadística descriptiva e inferencial en el programa SPSS V.21. Resultados. El 66.6% de los participantes eran hombres, 58.0% tenían licenciatura o posgrado, el 34.0% del personal tenía <10 años trabajando en el centro, el 100% sabía que era un medicamento citostático y el 67.0% tuvo un nivel de conocimiento medio sobre el manejo adecuado de desechos citostáticos. Conclusiones. Los antineoplásicos son considerados como fármacos de alta toxicidad, que pueden ser peligrosos no solo para los pacientes, sino también para el personal de salud sobre todo en aquellos que interviene en el tratamiento, almacenamiento, limpieza, traslado de pacientes e incluso al personal enfocado en procesos administrativo
Palabras clave: Palabras clave. Bioseguridad, Conocimiento, Citostático, Equipo de Protección Personal.

ABSTRACT
Aim. To evaluate the level of knowledge about biosafety in the handling of cytostatic drugs that the personnel of a Specialized Center for Oncological Care. Material and methods. Cross-sectional exploratory research, carried out in a private Oncology Care Center in the city of San Luis Potosí. A validated instrument was applied to 12 participants to assess the level of knowledge, descriptive and inferential statistics were performed in the SPSS V.21 program. Results. 66.6% of the participants were men, 58.0% had a bachelor's or postgraduate degree, 34.0% of the staff had been working at the center for <10 years, 100% knew that it was a cytostatic drug and 67. 0% had a medium level of knowledge about the proper management of cytostatic waste. Conclusions. Antineoplastics are considered highly toxic drugs, which can be dangerous not only for patients, but also for health personnel, especially those involved in treatment, storage, cleaning, patient transfer, and even personnel focused on administrative processes.
Keywords. Biosecurity, Knowledge, Cytostatic, Personal Protective Equipment.

Referencias

  1. Sargidy AAW, Yahia A, Ahmad M, Abdalla M, Khalil SN, Alasary S, et al. Knowledge of safe handling, administration, and waste management of chemotherapeutic drugs among oncology nurses working at Khartoum Oncology Hospital, Sudan. PeerJ 2022;10:e14173.
  2. Boakye D, Günther K, Niedermaier T, Haug U, Ahrens W, Nagrani R. Associations between comorbidities and advanced stage diagnosis of lung, breast, colorectal, and prostate cancer: A systematic review and meta-analysis. Cancer Epidemiol 2021;75:102054.
  3. Medina-de la Cruz O, Escoto-Chávez SE, Gaytán-Hernández D, Villegas-Hinojosa E, Terán-Figuera Y, Gallegos-García V. Identificación del polimorfismo en la MMP-7-181A>G en mujeres potosinas con neoplasia intraepitelial cervical. Inv Cienc UAA 2021;(82):33-41.
  4. Anttila JV, Shubin M, Cairns J, Borse F, Guo Q, Mononen T, et al. Contrasting the impact of cytotoxic and cytostatic drug therapies on tumour progression. PLoS Comput Biol. 2019;15(11):e1007493.
  5. Asefa S, Aga F, Dinegde NG, Demie TG. Knowledge and Practices on the Safe Handling of Cytotoxic Drugs Among Oncology Nurses Working at Tertiary Teaching Hospitals in Addis Ababa, Ethiopia. Drug Healthc Patient Saf 2021;13:71-80.
  6. Gajski G, Ladeira C, Gerić M, Garaj-Vrhovac V, Viegas S. Genotoxicity assessment of a selected cytostatic drug mixture in human lymphocytes: A study based on concentrations relevant for occupational exposure. Environ Res. 2018;161:26-34.
  7. Simegn W, Dagnew B, Dagne H. Knowledge and associated factors towards cytotoxic drug handling among University of Gondar Comprehensive Specialized Hospital health professionals, institutional-based cross-sectional study. Environ Health Prev Med 2020;25:11.
  8. Varela-Díaz V, Pérez-Villa. M. Medidas de bioseguridad en la manipulación de medicamentos citotóxicos y signos y síntomas de la exposición al riesgo en el personal de enfermería. Rev Salud Bosque 2020; 10 (1): 32-40.
  9. Ghasemi L, Yousefzadeh S, Rastkari N, Naddafi K, Shariati Far N, Nabizadeh R. Evaluate the types and amount of genotoxic waste in Tehran University of Medical Science’s hospitals. J Environ Health Sci Eng 2018;16(2):171-179.
  10. Capoor MR, Bhowmik KT. Cytotoxic Drug Dispersal, Cytotoxic Safety, and Cytotoxic Waste Management: Practices and Proposed India-specific Guidelines. Indian J Med Paediatr Oncol Off 2017;38(2):190-197.
  11. El-Ebiary AA, Abuelfadl AA, Sarhan NI. Evaluation of genotoxicity induced by exposure to antineoplastic drugs in lymphocytes of oncology nurses and pharmacists. J Appl Toxicol 2013; 33 (3): 196-201.
  12. Lancharro PM, Iglesias CA, González-Barcala FJ, González JDM. Evidence of exposure to cytostatic drugs in healthcare staff: a review of recent literature. Farm Hosp 2016;40(6):604-621.
  13. Baniasadi S, Alehashem M, Yunesian M, Rastkari N. Biological Monitoring of Healthcare Workers Exposed to Antineoplastic Drugs: Urinary Assessment of Cyclophosphamide and Ifosfamide. Iran J Pharm Res IJPR 2018;17(4):1458-1464.
  14. Mamani-Arizapana SM. Conocimientos que tienen las enfermeras sobre los riesgos en la manipulación de citostáticos, en el Servicio de Pediatría del INEN - 2010. Facultad de Medicina Humana. Universidad Nacional Mayor de San Marcos. Lima. 2010.
  15. Simegn W, Dagnew B, Dagne H. Knowledge and associated factors towards cytotoxic drug handling among University of Gondar Comprehensive Specialized Hospital health professionals, institutional-based cross-sectional study. Environ Health Prev Med 2020; 25 (11): 1-8.
  16. DOF. Norma Oficial Mexicana NOM-087-ECOL-SSA1-2022, Protección ambiental, salud ambiental, residuos peligrosos biológicos infecciosos, clasificación y especificaciones de manejo. Cassio Luiselli Fernández, México, Distrito Federal, 17-02-2003 [06-02-2023]. Disponible en https://www.cndh.org.mx/DocTR/2016/JUR/A70/01/JUR-20170331-NOR14.pdf
  17. Boughattas AB, Bouraoui S, Debbabi F, El Ghazel H, Saad A, Mrizak N. Genotoxic risk assessment of nurses handling antineoplastic drugs. Ann Biol Clin (Paris) 2010;68(5):545-553.
  18. Pieri M, Castiglia L, Basilicata P, Sannolo N, Acampora A, Miraglia N. Biological monitoring of nurses exposed to doxorubicin and epirubicin by a validated liquid chromatography/fluorescence detection method. Ann Occup Hyg 2010;54(4):368-376.
  19. Bouraoui S, Brahem A, Tabka F, Mrizek N, Saad A, Elghezal H. Assessment of chromosomal aberrations, micronuclei and proliferation rate index in peripheral lymphocytes from Tunisian nurses handling cytotoxic drugs. Environ Toxicol Pharmacol 2011;31(1):250-257.
  20. Friese CR, McArdle C, Zhao T, Sun D, Spasojevic I, Polovich M, et al. Antineoplastic drug exposure in an ambulatory setting: a pilot study. Cancer Nurs 2015;38(2):111-117.
  21. Leso V, Sottani C, Santocono C, Russo F, Grignani E, Iavicoli I. Exposure to Antineoplastic Drugs in Occupational Settings: A Systematic Review of Biological Monitoring Data. Int J Environ Res Public Health 2022; 19(6):3737.
  22. Rittidet C, Chaiear N. Attitude and relationship with chemotherapy of personality in a university hospital in the Northeast region. Srinagarind Med J 2021;36(4):444-450.
  23. Ha Z, Sm S, Rm ES, Wm S. Knowledge, attitudes and practices of safe handling of cytotoxic drugs among oncology nurses in tanta university hospitals. Egypt J Occup Med 2019;43(1):75-92.
  24. Momeni M, Danaei M, Askarian M. How do nurses manage their occupational exposure to cytotoxic drugs? A descriptive survey in chemotherapy settings, Shiraz, Iran. Int J Occup Environ Med 2013;4(2):102-106.
  25. Walton AL, Kneipp S, Linnan L, et al. Nursing Assistants’ Use of Personal Protective Equipment Regarding Contact With Excreta Contaminated With Antineoplastic Drugs. Oncol Nurs Forum 2019;46(6):689-700.
  26. Alehashem M, Baniasadi S. Safe Handling of Anti-Neoplastic Drugs in the University Hospitals: A Descriptive Survey Study Among Oncology Nurses. Int J Cancer Manag 2018; 11 (2): :e6482.
  27. Elshamy K, El-Hadidi M, El-Roby M, Fouda M. Health Hazards among Oncology Nurses Exposed to Chemotherapy Drugs. Afr J Haematol Oncol 2010;1(3).